Cryptosporidium represents a group of early-branched apicomplexans. Various Cryptosporidium species may infect humans and/or animals, causing cryptosporidiosis for which no completely effective treatments are yet available. The chapter provides updated information on Cryptosporidium in the basic parasitology (e.g., taxonomy, life cycle, genotypes, and treatments), genomics (e.g., general features of the genomes, comparison between C. parvum and C. hominis genomes, genome maps, genome databases, and resources), and the insights into the Cryptosporidium biology delineated from the genomes, including streamlined metabolism, expanded families of transporters, lineage-specific expansion of proteases, Cryptosporidium-specific amplified gene families, surface protein repertoire, mucin-like proteins, TRAP family of motility and invasion proteins, oocyst wall proteins, and potential drug targets.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Abrahamsen MS, Templeton TJ, Enomoto S, Abrahante JE, Zhu G, Lancto CA, Deng M, Liu C, Widmer G, Tzipori S, Buck GA, Xu P, Bankier AT, Dear PH, Konfortov BA, Spriggs HF, Iyer L, Anantharaman V, Aravind L, Kapur V (2004) Complete genome sequence of the apicomplexanCrypt-osporidium parvum. Science 304:441–445
Aiello AE, Xiao L, Limor JR, Liu C, Abrahamsen MS, Lal AA (1999) Microsatellite analysis of the human and bovine genotypes ofCryptosporidiumparvum. J Eukaryot Micro-biol 46:46S–47S
Alvarez-Pellitero P, Sitja-Bobadilla A (2002)Cryptosporidium molnarin. sp. (Apicomplexa: Cryptosporidiidae) infecting two marine fish speciesSparus aurataL. andDicentra-rchus labraxL. Int J Parasitol 32:1007–1021
Amadi B, Mwiya M, Musuku J, Watuka A, Sianongo S, Ayoub A, Kelly P (2002) Effect of nitazoxanide on morbidity and mortality in Zambian children with cryptosporidiosis: a randomised controlled trial. Lancet 360:1375–1380
Anderson DR, Duszynski DW, Marquardt WC (1968) Three new coccidia (Protozoa: Telosporea) from kingsnakesLampropeltisspp., in Illinois, with a redescription ofEime-ria zamenisPhisalix, 1921. J Parasitol 54:577–581
Aurrecoechea C, Heiges M, Wang H, Wang Z, Fischer S, Rhodes P, Miller J, Kraemer E, Stoeckert CJ Jr, Roos DS, Kissinger JC (2006) ApiDB: integrated resources for the apicompl-exan bioinformatics resource center. Nucl Acids Res 35 (Database issue):D427–D430
Bankier AT, Spriggs HF, Fartmann B, Konfortov BA, Madera M, Vogel C, Teichmann SA, Ivens A, Dear PH (2003) Integrated mapping, chromosomal sequencing and sequence analysis ofCryptosporidium parvum. Genom Res 13:1787–1799
Barnes DA, Bonnin A, Huang JX, Gousset L, Wu J, Gut J, Doyle P, Dubremetz JF, Ward H, Petersen C (1998) A novel multi-domain mucin-like glycoprotein ofCryptosporidium par-vummediates invasion. Mol Biochem Parasitol 96:93–110
Barta JR, Thompson RC (2006) What isCryptosporidium? Reappraising its biology and phylogenetic affinities. Trends Parasitol 22:463–468
Bearup AJ (1954) The coccidia of carnivores of Sydney. Aust Ve t J 30:185–186
Bonnin A, Ojcius DM, Souque P, Barnes DA, Doyle PS, Gut J, Nelson RG, Petersen C, Dubremetz JF (2001) Characterization of a monoclonal antibody reacting with antigen-4 domain of gp900 inCryptosporidium parvuminvasive stages. Parasitol Res 87:589–592
Brends SJ (1989–2005) Systema Naturae 2000 The Taxonomi-con. Universal Taxonomic Services, Amsterdam, The Netherlands. [http://sn2000.taxonomy.nl/Taxonomicon/]. Access date: Nov 23, 2005
Bull S, Chalmers R, Sturdee A P, Curry A, Kennaugh J (1998) Cross-reaction of an anti-Cryptosporidiummonoclonalantibody with sporocysts of Monocystis species. Vet Para-sitol 77:195–197
Byington CL, Dunbrack RL, Jr., Cohen FE, Agabian N (1997a) Molecular modeling of phosphofructokinase fromEnta-moeba histolyticafor the prediction of new antiparasitic agents. Arch Med Res 28(Spec No):86–88
Byington CL, Dunbrack RL, Jr., Whitby FG, Cohen FE, Agabian N (1997b)Entamoeba histolytica: computer-assisted modeling of phosphofructokinase for the prediction of broad-spectrum antiparasitic agents. Exp Parasitol 87:194–202
Caccio S, Homan W, Camilli R, Traldi G, Kortbeek T, Pozio E (2000) A microsatellite marker reveals population heterogeneity within human and animal genotypes ofCrypt-osporidium parvum. Parasitology 120(Pt 3):237–244
Caccio S, Homan W, van Dijk K, Pozio E (1999) Genetic polymorphism at the beta-tubulin locus among human and animal isolates ofCryptosporidium parvum. FEMS Micro-biol Lett 170:173–179
Cai X, Lancto CA, Abrahamsen MS, Zhu G (2004) Intron-containing beta-tubulin transcripts inCryptosporidium parvumcultured in vitro. Microbiology 150:1191–1195
Carreno RA, Martin DS, Barta JR (1999)Cryptosporidiumis more closely related to the gregarines than to coccidia as shown by phylogenetic analysis of apicomplexan parasites inferred using small-subunit ribosomal RNA gene sequences. Parasitol Res 85:899–904
Carruthers VB, Sibley LD (1997) Sequential protein secretion from three distinct organelles ofToxoplasma gondiiaccompanies invasion of human fibroblasts. Eur J Cell Biol 73:114–123
Cevallos AM, Bhat N, Verdon R, Hamer DH, Stein B, Tzipori S, Pereira ME, Keusch GT, Ward HD (2000) Mediation ofCryptosporidium parvuminfection in vitro by mucin-like glycoproteins defined by a neutralizing monoclonal antibody. Infect Immun 68:5167–5175
Chen XM, LaRusso NF (2000) Mechanisms of attachment and internalization ofCryptosporidium parvumto biliary and intestinal epithelial cells. Gastroenterology 118:368–379
Ctrnacta V, Ault JG, Stejskal F, Keithly JS (2006) Localization of pyruvate:NADP+ oxidoreductase in sporozoites ofCrypt-osporidium parvum. J Eukaryot Microbiol 53:225–231
Current WL, Reese NC (1986) A comparison of endogenous development of three isolates ofCryptosporidiumin suckling mice. J Protozool 33:98–108
Current WL, Upton SJ, Haynes TB (1986) The life cycle ofCryptosporidium baileyin. sp. (Apicomplexa, Cryptospori-diidae) infecting chickens. J Protozool 33:289–296
Delrieu I, Waller CC, Mota MM, Grainger M, Langhorne J, Holder AA (2002) PSLAP, a protein with multiple adhesive motifs, is expressed inPlasmodium falciparumgameto-cytes. Mol Biochem Parasitol 121:11–20
Deng M, Templeton TJ, London NR, Bauer C, Schroeder AA, Abrahamsen MS (2002)Cryptosporidium parvumgenescontaining thrombospondin type 1 domains. Infect Immun 70:6987–6995
Dorn A, Vippagunta SR, Matile H, Jaquet C, Vennerstrom JL, Ridley RG (1998) An Assessment of drug-haematin binding as a mechanism for inhibition of haematin polymerization by quinoline antimalarials. Biochem Pharmacol 55:727–736
Doumbo O, Rossignol JF, Pichard E, Traore HA, Dembele TM, Diakite M, Traore F, Diallo DA (1997) Nitazoxanide in the treatment of cryptosporidial diarrhea and other intestinal parasitic infections associated with acquired immunodeficiency syndrome in tropical Africa. Am J Trop Med Hyg 56:637–639
Dubey JP, Pande BP (1963) Observations on the coccidian oocysts from Indian Jungle cat (Felis chaus). Ind J Micro-biol 3:103–108
Duszynski DW (1969) Two new coccidia (Protozoa: Dimerii-dae) from Costa Rican lizards with a review of theEimeriafrom lizards. J Protozool 16:581–585
Egyed Z, Sreter T, Szell Z, Beszteri B, Dobos-Kovacs M, Maria-ligeti K, Cornelissen AW, Varga I (2002) Polyphasic typing ofCryptosporidium baileyi: a suggested model for characterization of cryptosporidia. J Parasitol 88:237–243
Egyed Z, Sreter T, Szell Z, Varga I (2003) Characterization ofCryptosporidiumspp. — recent developments and future needs. Vet Parasitol 111:103–114
Eisen JA, Coyne RS, Wu M, Wu D, Thiagarajan M, Wortman JR, Badger JH, Ren Q, Amedeo P, Jones KM, Tallon LJ, Delcher AL, Salzberg SL, Silva JC, Haas BJ, Majoros WH, Farzad M, Carlton JM, Smith RK Jr., Garg J, Pearlman RE, Karrer KM, Sun L, Manning G, Elde NC, Turkewitz A P, Asai DJ, Wilkes DE, Wang Y, Cai H, Collins K, Stewart BA, Lee SR, Wilamowska K, Weinberg Z, Ruzzo WL, Wloga D, Gaer-tig J, Frankel J, Tsao CC, Gorovsky MA, Keeling PJ, Waller RF, Patron NJ, Cherry JM, Stover NA, Krieger CJ, del Toro C, Ryder HF, Williamson SC, Barbeau RA, Hamilton E P, Orias E (2006) Macronuclear genome sequence of the cili-ateTetrahymena thermophila, a model eukaryote. PLoS Biol 4:e286
Espinosa A, Clark D, Stanley SL Jr (2004)Entamoeba histo-lyticaalcohol dehydrogenase 2 (EhADH2) as a target for anti-amoebic agents. J Antimicrob Chemother 54:56–59
Esposito M, Stettler R, Moores SL, Pidathala C, Muller N, Sta-chulski A, Berry NG, Rossignol JF, Hemphill A (2005) In vitro efficacies of nitazoxanide and other thiazolides againstNeospora caninumtachyzoites reveal antipara-sitic activity independent of the nitro group. Antimicrob Agents Chemother 49:3715–3723
Fayer R (1997)Cryptosporidiumand cryptosporidiosis. CRC Press, Boca Raton, Florida, USA
Fayer R, Morgan U, Upton SJ (2000) Epidemiology ofCrypt-osporidium: transmission, detection and identification. Int J Parasitol 30:1305–1322
Fayer R, Santin M, Xiao L (2005)Cryptosporidium bovisn. sp. (Apicomplexa: Cryptosporidiidae) in cattle (Bos taurus). J Parasitol 91:624–629
Fayer R, Trout JM, Xiao L, Morgan UM, Lai AA, Dubey JP (2001)Cryptosporidium canisn. sp. from domestic dogs. J Parasi-tol 87:1415–1422
Fayer R, Ungar BL (1986)Cryptosporidiumspp. and crypt-osporidiosis. Microbiol Rev 50:458–483
Feng X, Rich SM, Akiyoshi D, Tumwine JK, Kekitiinwa A, Nabukeera N, Tzipori S, Widmer G (2000) Extensive polymorphism inCryptosporidium parvumidentified by mul-tilocus microsatellite analysis. Appl Environ Microbiol 66:3344–3349
Fox LM, Saravolatz LD (2005) Nitazoxanide: a new thiazolide antiparasitic agent. Clin Infect Dis 40:1173–1180
Fritzler JM, Zhu G (2007) Functional characterization of the acyl-[acyl carrier protein] ligase in theCryptosporidium parvumgiant polyketide synthase. Int J Parasitol 37(3– 4):307–316
Galazka J, Striepen B, Ullman B (2006) Adenosine kinase fromCryptosporidium parvum. Mol Biochem Parasitol 149:223–230
Gardner MJ, Bishop R, Shah T, de Villiers E P, Carlton JM, Hall N, Ren Q, Paulsen IT, Pain A, Berriman M, Wilson RJ, Sato S, Ralph SA, Mann DJ, Xiong Z, Shallom SJ, Weidman J, Jiang L, Lynn J, Weaver B, Shoaibi A, Domingo AR, Wasawo D, Crabtree J, Wortman JR, Haas B, Angiuoli S V, Creasy TH, Lu C, Suh B, Silva JC, Utterback TR, Feldblyum T V, Pertea M, Allen J, Nierman WC, Taracha EL, Salzberg SL, White OR, Fitzhugh HA, Morzaria S, Venter JC, Fraser CM, Nene V (2005) Genome sequence ofTheileria parva, a b o v i n e p a t h -ogen that transforms lymphocytes. Science 309:134–137
Gardner MJ, Hall N, Fung E, White O, Berriman M, Hyman RW, Carlton JM, Pain A, Nelson KE, Bowman S, Paulsen IT, James K, Eisen JA, Rutherford K, Salzberg SL, Craig A, Kyes S, Chan MS, Nene V, Shallom SJ, Suh B, Peterson J, Angiuoli S, Pertea M, Allen J, Selengut J, Haft D, Mather MW, Vaidya AB, Martin DM, Fairlamb AH, Fraunholz MJ, Roos DS, Ralph SA, McFadden GI, Cummings LM, Subramanian GM, Mungall C, Venter JC, Carucci DJ, Hoffman SL, New-bold C, Davis RW, Fraser CM, Barrell B (2002) Genome sequence of the human malaria parasitePlasmodium fal-ciparum. Nature 419:498–511
Hampton JC, Rosario B (1966) The attachment of protozoan parasites to intestinalepithelial cells of the mouse. J Para-sitol 52:939–949
Harth G, Horwitz MA (1999) An inhibitor of exportedMyco-bacterium tuberculosisglutamine synthetase selectively blocks the growth of pathogenic mycobacteria in axenic culture and in human monocytes: extracellular proteins as potential novel drug targets. J Exp Med 189:1425–1436
Harth G, Horwitz MA (2003) Inhibition ofMycobacterium tuberculosisglutamine synthetase as a novel antibioticstrategy against tuberculosis: demonstration of efficacy in vivo. Infect Immun 71:456–464
Heiges M, Wang H, Robinson E, Aurrecoechea C, Gao X, Kaluskar N, Rhodes P, Wang S, He CZ, Su Y, Miller J, Kraemer E, Kissinger JC (2006) CryptoDB: aCryptosporidiumbioinformat-ics resource update. Nucl Acids Res 34:D419–D422
Hemphill A, Mueller J, Esposito M (2006) Nitazoxanide, a broad-spectrum thiazolide anti-infective agent for the treatment of gastrointestinal infections. Expert Opin Pharmacother 7:953–964
Hewitt RG, Yiannoutsos CT, Higgs ES, Carey JT, Geiseler PJ, Soave R, Rosenberg R, Vazquez GJ, Wheat LJ, Fass RJ, Antoninievic Z, Walawander AL, Flanigan TP, Bender JF (2000) Paromomycin: no more effective than placebo for treatment of cryptosporidiosis in patients with advanced human immunodeficiency virus infection. AIDS Clinical Trial Group. Clin Infect Dis 31:1084–1092
Hijjawi NS, Meloni BP, Ng'anzo M, Ryan UM, Olson ME, Cox PT, Monis PT, Thompson RC (2004) Complete development ofCryptosporidium parvumin host cell-free culture. Int J Parasitol 34:769–777
Hijjawi NS, Meloni BP, Ryan UM, Olson ME, Thompson RC (2002) Successful in vitro cultivation ofCryptosporidium andersoni: evidence for the existence of novel extracellular stages in the life cycle and implications for the classification of Cryptosporidium. Int J Parasitol 32:1719–1726
Hommer V, Eichholz J, Petry F (2003) Effect of antiretrovi-ral protease inhibitors alone, and in combination with paromomycin, on the excystation, invasion and in vitro development ofCryptosporidium parvum. J Antimicrob Chemother 52:359–364
Iseki M (1979)Cryptosporidium felissp. n. (Protozoa: Eimerio-rina) from the domestic cat. Jpn J Parasitol 28:285–307
Jervis HR, Merrill TG, Sprinz H (1966) Coccidiosis in the guinea pig small intestine due to aCryptosporidium. A m J Ve t Res 27:408–414
Kadappu KK, Nagaraja MV, Rao PV, Shastry BA (2002) Azithro-mycin as treatment for cryptosporidiosis in human immunodeficiency virus disease. J Postgrad Med 48:179–181
Korich DG, Mead JR, Madore MS, Sinclair NA, Sterling CR (1990) Effects of ozone, chlorine dioxide, chlorine, and monochloramine onCryptosporidium parvumoocyst viability. Appl Environ Microbiol 56:1423–1428
Koudela B, Modry D (1998) New species ofCryptosporidium(Apicomplexa: Cryptosporidiidae) from lizards. Folia Par-asitol 45:93–100
Kubota T, Iinuma Y, Kobayashi J (2006) Cloning of polyketide synthase genes from amphidinolide-producing dinoflag-ellateAmphidiniumsp. Biol Pharm Bull 29:1314–1318
LaGier MJ, Tachezy J, Stejskal F, Kutisova K, Keithly JS (2003) Mitochondrial-type iron-sulfur cluster biosynthesis genes (IscS and IscU) in the apicomplexanCryptosporidium parvum. Microbiology 149:3519–3530
Levine ND (1961) Protozoan parasites of domestic animals and of man. Burgess, Minneapolis
Levine ND (1980) Some corrections of coccidian (Apicompl-exa: Protozoa) nomenclature. J Parasitol 66:830–834
Levine ND (1984) Taxonomy and review of the coccidian genusCryptosporidium(protozoa, apicomplexa). J Protozool 31:94–98
Levine ND (1985) Phylum II. Apicomplexa Levine, 1970. In: Lee JJ, SH Hunter, EC Bovee (ed.) An illustrated guide to the Protozoa. Allen Press, Lawrence, KS, pp 322–374
Lindsay DS, Upton SJ, Owens DS, Morgan UM, Mead JR, Blag-burn BL (2000)Cryptosporidiumandersoni n. sp. (Api-complexa: Cryptosporiidae) from cattle, Bos taurus. J Eukaryot Microbiol 47:91–95
Liu C, Vigdorovich V, Kapur V, Abrahamsen MS (1999) A random survey of theCryptosporidium parvumgenome. Infect Immun 67:3960–3969
Marshall MM, Naumovitz D, Ortega Y, Sterling CR (1997) Waterborne protozoan pathogens. Clin Microbiol Rev 10:67–85
McManus DP, Bowles J (1996) Molecular genetic approaches to parasite identification: their value in diagnostic parasitol-ogy and systematics. Int J Parasitol 26:687–704
Meisel JL, Perera DR, Meligro C, Rubin CE (1976) Overwhelming watery diarrhea associated with aCryptosporidiumin an immunosuppressed patient. Gastroenterology 70:1156– 1160
Menting JG, Tilley L, Deady LW, Ng K, Simpson RJ, Cowman AF, Foley M (1997) The antimalarial drug, chloroquine, interacts with lactate dehydrogenase fromPlasmodium falciparum. Mol Biochem Parasitol 88:215–224
Morgan-Ryan UM, Fall A, Ward LA, Hijjawi N, Sulaiman I, Fayer R, Thompson RC, Olson M, Lal A, Xiao L (2002)Cryptosporidium hominisn. sp. (Apicomplexa: Crypt-osporidiidae) fromHomo sapiens. J Eukaryot Microbiol 49:433–440
Morgan-Ryan UM, Monis P, Possenti A, Crisanti A, Spano F (2001) Cloning and phylogenetic analysis of the ribosomal internal transcribed spacer-1 (ITS1) of Cryptosporidium wrairi and its relationship toC. parvumgenotypes. Par-assitologia 43:159–163
Nime FA, Burek JD, Page DL, Holscher MA, Yardley JH (1976) Acute enterocolitis in a human being infected with the protozoanCryptosporidium. Gastroenterology 70:592–598
O'Donoghue PJ (1995)Cryptosporidiumand cryptosporidiosis in man and animals. Int J Parasitol 25:139–195
Omoto CK, Toso M, Tang K, Sibley LD (2004) Expressed sequence tag (EST) analysis ofGregarinegametocyst development. Int J Parasitol 34:1265–1271
Pain A, Renauld H, Berriman M, Murphy L, Yeats CA, Weir W, Kerhornou A, Aslett M, Bishop R, Bouchier C, Cochet M, Coulson RM, Cronin A, de Villiers E P, Fraser A, Fosker N, Gardner M, Goble A, Griffiths-Jones S, Harris DE, Katzer F, Larke N, Lord A, Maser P, McKellar S, Mooney P, Morton F, Nene V, O'Neil S, Price C, Quail MA, Rabbinowitsch E, Rawlings ND, Rutter S, Saunders D, Seeger K, Shah T, Squares R, Squares S, Tivey A, Walker AR, Woodward J, Dobbelaere DA, Langsley G, Rajandream MA, McKeever D, Shiels B, Tait A, Barrell B, Hall N (2005) Genome of the host-cell transforming parasiteTheileria annulatacompared withT. parva. Science 309:131–133
Pande BP, Bhatia BB, Chauhan PP (1972) A new genus and species of cryptosporidiid Coccidia from India. Acta Ve t Acad Sci Hung 22:231–234
Pankiewicz KW, Patterson SE, Black PL, Jayaram HN, Risal D, Goldstein BM, Stuyver LJ, Schinazi RF (2004) Cofactor mimics as selective inhibitors of NAD-dependent inosine monophosphate dehydrogenase (IMPDH) — the major therapeutic target. Curr Med Chem 11:887–900
Pankuch GA, Appelbaum PC (2006) Activities of tizoxanide and nitazoxanide compared to those of five other thia-zolides and three other agents against anaerobic species. Antimicrob Agents Chemother 50:1112–1117
Perkins ME, Riojas YA, Wu TW, Le Blancq SM (1999) CpABC, aCryptosporidium parvumATP-binding cassette protein at the host-parasite boundary in intracellular stages. Proc Natl Acad Sci USA 96:5734–5739
Pfefferkorn ER, Bzik DJ, Honsinger CP (2001)Toxoplasma gon-dii: mechanism of the parasitostatic action of 6-thioxan-thine. Exp Parasitol 99:235–243
Pradel G, Hayton K, Aravind L, Iyer LM, Abrahamsen MS, Bonawitz A, Mejia C, Templeton TJ (2004) A multidomain adhesion protein family expressed inPlasmodium falci-parumis essential for transmission to the mosquito. J Exp Med 199:1533–1544
Read JA, Wilkinson KW, Tranter R, Sessions RB, Brady RL (1999) Chloroquine binds in the cofactor binding site ofPlasmodium falciparumlactate dehydrogenase. J Biol Chem 274:10213–10218
Reduker DW, Speer CA, Blixt JA (1985) Ultrastructure ofCrypt-osporidium parvumoocysts and excysting sporozoites as revealed by high resolution scanning electron microscopy. J Protozool 32:708–711
Rein KS, Snyder RV (2006) The biosynthesis of polyketide metabolites by dinoflagellates. Adv Appl Microbiol 59:93–125
Riordan CE, Ault JG, Langreth SG, Keithly JS (2003)Crypt-osporidium parvumCpn60 targets a relict organelle. Curr Genet 44:138–147
Roberts CW, Roberts F, Henriquez FL, Akiyoshi D, Samuel BU, Richards TA, Milhous W, Kyle D, McIntosh L, Hill GC, Chaudhuri M, Tzipori S, McLeod R (2004) Evidence for mitochondrial-derived alternative oxidase in the apicom-plexan parasiteCryptosporidium parvum: a potential antimicrobial agent target. Int J Parasitol 34:297–308
Rochelle PA, Jutras EM, Atwill ER, De Leon R, Stewart MH (1999) Polymorphisms in the beta-tubulin gene ofCryptosporidium parvumdifferentiate between isolates based on animal host but not geographic origin. J Para-sitol 85:986–989
Romero Cabello R, Guerrero LR, Munoz Garcia MR, Geyne Cruz A (1997) Nitazoxanide for the treatment of intestinal protozoan and helminthic infections in Mexico. Trans R Soc Trop Med Hyg 91:701–703
Rosales MJ, Cordon GP, Moreno MS, Sanchez CM (2005) Extracellular like-gregarine stages ofCryptosporidium parvum. Acta Trop 95:74–78
Rossignol JF (2006) Nitazoxanide in the treatment of acquired immune deficiency syndrome-related cryptosporidiosis: results of the United States compassionate use program in 365 patients. Aliment Pharmacol Ther 24:887–894
Rossignol JF, Ayoub A, Ayers MS (2001) Treatment of diarrhea caused byCryptosporidium parvum: a prospective randomized, double-blind, placebo-controlled study of Nita-zoxanide. J Infect Dis 184:103–106
Rossignol JF, Maisonneuve H (1984) Nitazoxanide in the treatment of Taenia saginata and Hymenolepis nana infections. Am J Trop Med Hyg 33:511–512
Rotte C, Stejskal F, Zhu G, Keithly JS, Martin W (2001) Pyru-vate: NADP+ oxidoreductase from the mitochondrion of Euglena gracilis and from the apicomplexan Cryptosporid-ium parvum: a biochemical relic linking pyruvate metabolism in mitochondriate and amitochondriate protists. Mol Biol Evol 18:710–720
Ryan UM, Monis P, Enemark HL, Sulaiman I, Samarasinghe B, Read C, Buddle R, Robertson I, Zhou L, Thompson RC, Xiao L (2004) Cryptosporidium suis n. sp. (Apicomplexa: Crypt-osporidiidae) in pigs (Sus scrofa). J Parasitol 90:769–773
Ryan UM, Xiao L, Read C, Sulaiman IM, Monis P, Lal AA, Fayer R, Pavlasek I (2003) A redescription of Cryptosporidium galli Pavlasek, 1999 (Apicomplexa: Cryptosporidiidae) from birds. J Parasitol 89:809–813
Sibley LD (2004) Intracellular parasite invasion strategies. Science 304:248–253
Sitja-Bobadilla A, Padros F, Aguilera C, Alvarez-Pellitero P (2005) Epidemiology of Cryptosporidium molnari in Spanish gilthead sea bream (Sparus aurata L.) and European sea bass (Dicentrarchus labrax L.) cultures: from hatchery to market size. Appl Environ Microbiol 71:131–139
Slapeta J, Keithly JS (2004) Cryptosporidium parvum mito-chondrial-type HSP70 targets homologous and heterolo-gous mitochondria. Eukaryot Cell 3:483–494
Slavin D (1955) Cryptosporidium meleagridis (sp. nov.). J Comp Pathol 65:262–266
Smith H V, Nichols RAB, Grimason AM (2005) Cryptosporid-ium excystation and invasion: getting to the guts of the matter. Trends Parasitol 21:133–142
Smith NH, Cron S, Valdez LM, Chappell CL, White AC Jr (1998) Combination drug therapy for cryptosporidiosis in AIDS. J Infect Dis 178:900–903
Snyder RV, Gibbs PD, Palacios A, Abiy L, Dickey R, Lopez J V, Rein KS (2003) Polyketide synthase genes from marine dinoflagellates. Mar Biotechnol (NY) 5:1–12
Snyder RV, Guerrero MA, Sinigalliano CD, Winshell J, Perez R, Lopez J V, Rein KS (2005) Localization of polyketide syn-thase encoding genes to the toxic dinoflagellate Karenia brevis. Phytochemistry 66:1767–1780
Spano F, Crisanti A (2000) Cryptosporidium parvum: the many secrets of a small genome. Int J Parasitol 30:553–565
Spano F, Puri C, Ranucci L, Putignani L, Crisanti A (1997) Cloning of the entire COWP gene of Cryptosporidium parvum and ultrastructural localization of the protein during sexual parasite development. Parasitology 114(Pt 5):427–437
Striepen B, Kissinger JC (2004) Genomics meets transgenics in search of the elusive Cryptosporidium drug target. Trends Parasitol 20:355–358
Striepen B, Pruijssers AJ, Huang J, Li C, Gubbels MJ, Umejiego NN, Hedstrom L, Kissinger JC (2004) Gene transfer in the evolution of parasite nucleotide biosynthesis. Proc Natl Acad Sci USA 101:3154–3159
Striepen B, White MW, Li C, Guerini MN, Malik SB, Logsdon JM Jr., Liu C, Abrahamsen MS (2002) Genetic complementation in apicomplexan parasites. Proc Natl Acad Sci USA 99:6304–6309
Strong WB, Nelson RG (2000a) Gene discovery in Cryptosporid-ium parvum: expressed sequence tags and genome survey sequences. Contrib Microbiol 6:92–115
Strong WB, Nelson RG (2000b) Preliminary profile of the Cryptosporidium parvum genome: an expressed sequence tag and genome survey sequence analysis. Mol Biochem Parasitol 107:1–32
Stwora-Wojczyk MM, Kissinger JC, Spitalnik SL, Wojczyk BS (2004) O-glycosylation in Toxoplasma gondii: identification and analysis of a family of UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferases. Int J Parasitol 34:309–322
Sulaiman IM, Lal AA, Arrowood MJ, Xiao L (1999) Biallelic polymorphism in the intron region of beta-tubulin gene of Cryptosporidium parasites. J Parasitol 85:154–157
Suzuki T, Hashimoto T, Yabu Y, Kido Y, Sakamoto K, Nihei C, Hato M, Suzuki S, Amano Y, Nagai K, Hosokawa T, Mina-gawa N, Ohta N, Kita K (2004) Direct evidence for cyanide-insensitive quinol oxidase (alternative oxidase) in apicomplexan parasite Cryptosporidium parvum: phy-logenetic and therapeutic implications. Biochem Biophys Res Commun 313:1044–1052
Tekos A, Prodromaki E, Papadimou E, Pavlidou D, Tsambaos D, Drainas D (2003) Aminoglycosides suppress tRNA processing in human epidermal keratinocytes in vitro. Skin Pharmacol Appl Skin Physiol 16:252–258
Templeton TJ, Iyer LM, Anantharaman V, Enomoto S, Abra-hante JE, Subramanian GM, Hoffman SL, Abrahamsen MS, Aravind L (2004a) Comparative analysis of apicomplexa and genomic diversity in eukaryotes. Genom Res 14:1686–1695
Templeton TJ, Lancto CA, Vigdorovich V, Liu C, London NR, Hadsall KZ, Abrahamsen MS (2004b) The Cryptosporidium oocyst wall protein is a member of a multigene family and has a homolog in Toxoplasma. Infect Immun 72:980–987
Tetley L, Brown SM, McDonald V, Coombs GH (1998) Ultrastructural analysis of the sporozoite of Cryptosporid-ium parvum. Microbiology 144 (Pt 12):3249–3255
Thompson RC, Olson ME, Zhu G, Enomoto S, Abrahamsen MS, Hijjawi NS (2005) Cryptosporidium and cryptosporidiosis. Adv Parasitol 59:77–158
Tosini F, Agnoli A, Mele R, Gomez Morales MA, Pozio E (2004) A new modular protein of Cryptosporidium parvum, w i t h ricin B and LCCL domains, expressed in the sporozoite invasive stage. Mol Biochem Parasitol 134:137–147
Triffitt MJ (1925) Observations on two new species of coccidia parasitic in snakes. Protozoology 1:19–26
Tyzzer EE (1907) A sporozoan found in the peptic glands of the common mouse. Proc Soc Exp Biol Med 5:12–13
Tyzzer EE (1912) Cryptosporidium parvum (sp. nov.), a coccid-ium found in the small intestine of the common mouse. Arch Protisenkd 26:394–412
Tzipori S (1998) Cryptosporidiosis: laboratory investigations and chemotherapy. Adv Parasitol 40:187–221
Tzipori S, Ward H (2002) Cryptosporidiosis: biology, patho-genesis and disease. Microbes Infect 4:1047–1058
Umemiya R, Fukuda M, Fujisaki K, Matsui T (2005) Electron microscopic observation of the invasion process of Crypt-osporidium parvum in severe combined immunodeficiency mice. J Parasitol 91:1034–1039
Upton SJ (2000) Suborder Eimeriorina Leger, 1911. In: Lee JJ, Leedale GF, Bradbury P (ed) The Illustrated Guide to the Protozoa, 2nd edn. Society of Protozoologists, Allen Press, Lawrence, KS, USA
Vetterling JM, Jervis HR, Merrill TG, Sprinz H (1971) Crypt-osporidium wrairi sp. n. from the guinea pig Cavia porcellus, with an emendation of the genus. J Protozool 18:243–247
White AC Jr (2003) Nitazoxanide: an important advance in anti-parasitic therapy. Am J Trop Med Hyg 68:382–383
Widmer G (2004) Population genetics of Cryptosporidium par-vum. Trends Parasitol 20:3–6 (discussion 6)
Widmer G, Tchack L, Chappell CL, Tzipori S (1998) Sequence polymorphism in the beta-tubulin gene reveals heterogeneous and variable population structures in Cryptosporidium parvum. Appl Environ Microbiol 64:4477–4481
Xiao L, Fayer R, Ryan U, Upton SJ (2004) Cryptosporidium taxonomy: recent advances and implications for public health. Clin Microbiol Rev 17:72–97
Xiao L, Limor J, Morgan UM, Sulaiman IM, Thompson RC, Lal AA (2000a) Sequence differences in the diagnostic target region of the oocyst wall protein gene of Cryptosporidium parasites. Appl Environ Microbiol 66:5499–5502
Xiao L, Morgan UM, Fayer R, Thompson RC, Lal AA (2000b) Cryptosporidium systematics and implications for public health. Parasitol Today 16:287–292
Xu P, Widmer G, Wang Y, Ozaki LS, Alves JM, Serrano MG, Puiu D, Manque P, Akiyoshi D, Mackey AJ, Pearson WR, Dear PH, Bankier AT, Peterson DL, Abrahamsen MS, Kapur V, Tzipori S, Buck GA (2004) The genome of Cryptosporid-ium hominis. Nature 431:1107–1112
Zapata F, Perkins ME, Riojas YA, Wu TW, Le Blancq SM (2002) The Cryptosporidium parvum ABC protein family. Mol Biochem Parasitol 120:157–161
Zhu G (2004) Current progress in the fatty acid metabolism in Cryptosporidium parvum. J Eukaryot Microbiol 51:381–388
Zhu G, Keithly JS, Philippe H (2000a) What is the phylogenetic position of Cryptosporidium? Int J Syst Evol Microbiol 50 (Pt 4):1673–1681
Zhu G, LaGier MJ, Stejskal F, Millership JJ, Cai X, Keithly JS (2002) Cryptosporidium parvum: the first protist known to encode a putative polyketide synthase. Gene 298:79–89
Zhu G, Li Y, Cai X, Millership JJ, Marchewka MJ, Keithly JS (2004) Expression and functional characterization of a giant Type I fatty acid synthase (CpFAS1) gene from Cryptosporidium parvum. Mol Biochem Parasitol 134: 127–135
Zhu G, Marchewka MJ, Keithly JS (2000b) Cryptosporidium parvum appears to lack a plastid genome. Microbiology 146(Pt 2):315–321
Zhu G, Marchewka MJ, Woods KM, Upton SJ, Keithly JS (2000c) Molecular analysis of a Type I fatty acid synthase in Cryptosporidium parvum. Mol Biochem Parasitol 105: 253–260
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Zhu, G., Enomoto, S., Fritzler, J.M., Abrahamsen, M.S., Templeton, T.J. (2009). Cryptosporidium . In: Nene, V., Kole, C. (eds) Genome Mapping and Genomics in Animal-Associated Microbes. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-74042-1_5
Download citation
DOI: https://doi.org/10.1007/978-3-540-74042-1_5
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-74040-7
Online ISBN: 978-3-540-74042-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)